Advertisement
Screener

Moleculin Biotech, Inc. (MBRX) Operating Loss Carryforwards

2.8 / 5 stars · 68/120 Roast Me

Moleculin Biotech, Inc. Operating Loss Carryforwards

Moleculin Biotech, Inc. (MBRX) had Operating Loss Carryforwards of $25.60 million as of 2019-12-31, per its 10-K filed 2020-03-19.

Discontinued › Notes › Income Taxes

us-gaap:OperatingLossCarryforwards · last filed 2020-03-19

  • 2019-12-31: Operating Loss Carryforwards $25.60M.
  • 2018-12-31: Operating Loss Carryforwards $15.10M.
  • 2017-12-31: Operating Loss Carryforwards $6.07M.
  • 2016-12-31: Operating Loss Carryforwards $1.53M.
Period endOperating Loss Carryforwards
2019-12-31$25.60M
10-K · filed 2020-03-19
2018-12-31$15.10M
10-K · filed 2019-02-21
2017-12-31$6.07M
10-K · filed 2018-03-28
2016-12-31$1.53M
10-K · filed 2017-04-03
2016-09-30$3.34M
10-Q · filed 2016-11-21
2016-06-30$1.70M
10-Q · filed 2016-11-21
2016-03-31$1.00M
10-Q · filed 2016-06-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33
Theriva Biologics, Inc. (TOVX)United States$0.011B
Dare Bioscience, Inc. (DARE)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92